|
Pharmaceutical Engineering Industry Interview Series
 |
| March/April 2008 - Rick Lawless, Associate Director, Strategic Support, Golden LEAF Biomanufacturing Training and Education Center (BTEC) |
| January/February 2008 - Uri Boneh, Director of Engineering, Global Generic Resources Group, Teva Pharmaceutical Industries Ltd. |
| November/December 2007 - Dr. Carl Lawton, Director of Massachusetts BioManufacturing Center (MBMC) and Associate Professor, Department of Chemical Engineering, UMass Lowell |
| September/October 2007 - Dr. Emilio Emini, Executive Vice President of Vaccine Research and Development, Wyeth Pharmaceuticals |
| July/August 2007 - Dr. Thomas Zimmer, Senior Vice President of the Corporate Division Safety, Quality, and Environmental Protection, Boehringer Ingelheim |
| May/June 2007 - Frederick Sexton, Senior Vice President, Technical Operations, Purdue Pharma |
| March/April 2007 - Richard S. Overton, Vice President of Operations and Facilities, Forest Laboratories |
| January/February 2007 - Lynn C. Gold, PhD, Vice President, Research and Process Development, Sonus Pharmaceuticals Inc. |
| November/December 2006 - Gordon Munro, PhD, Senior Vice President, Quality Assurance, Watson Pharmaceuticals |
| September/October 2006 - Phillip L. Gomez, PhD, MBA, Director of Vaccine Production, Dale and Betty Bumpers Vaccine Research Center, National Institute of Allergy and Infectious Diseases |
| July/August 2006 - Drs. Bernardus (Ben) N.M. Machielse, Senior Vice President, Operations, MedImmune, Inc. |
| May/June 2006 - Ron Branning, Vice President, Commercial Quality, Genentech |
| March/April 2006 - Norikazu Eiki, President and Representative Director, Bayer Yakuhin, Ltd. |
| January/February 2006 - Emer Cooke, Head of Sector, Inspections, Veterinary Medicines and Inspections, EMEA |
| September/October 2005 - Joe Morin, Vice President of Engineering, Human Genome Sciences, Inc. |
| March/April 2005 - Jeb Bush, Governor of Florida (reprint from CASA Newsletter) |
| May/June 2004 - George Fotiades, President and Chief Operating Officer, Cardinal Health, US |
| May/June 2003 - Ulrich Rudow, Vice President, Worldwide Engineering, Johnson & Johnson |
| November/December 2002 - Craig Muir, Vice President, Platform Technology Group, Millennium Pharmaceuticals, US |
| September/October 2002 - Frank S. Kohn, PhD, former Director of Manufacturing, Wyeth Vaccines, US |
| July/August 2001 - Founders of Clark, Richardson & Biskup - ISPE Company of the Year, US |
| July/August 1999 - Masayoshi Onoda, President and CEO, Yamanouchi Pharmaceutical Co., Ltd., Japan |
| September/October 1998 - Sidney Taurel, President and CEO, Eli Lilly & Co., US |
| July/August 1998 - John W. Galiardo, HIMA’s Chairman |
| January/February 1998 - Dr. Kurt Hausmann, Head of Global Technical Operations and Manufacturing, Hoffmann-La Roche, US |
| July/August 1997 - Larry W. Kranking, ISPE President, Vice President of Operations, Eisai Inc., US |
| September/October 1996 - William G. Thien, Vice President, Health Services, Walgreen Co., US |
| September/October 1995 - Dr. Brian McNamee, Managing Dir., CSL Ltd., Australia |
| July/August 1995 - Ken Chapman, President, Drumbeat Dimensions, US |
| May/June 1995 - Al Larson, CEO, TL Systems, US |
| January/February 1995 - James E. Rurka, President, CEO, Microcide Pharmaceuticals, US |
| November/December 1994 - Keith Stoneback, Corporate VP, Amsco, US |
| July/August 1994 - Stanley Newberger, Principal, CE&IC, US |
| May/June 1994 - Richard R. Klug, Director of International and Technical Operations Branch, FDA, US |
| March/April 1994 - Raymond Gilmartin, President, Becton Dickinson, US |
|
 |
|
